Shares of ArcBest (ARCB) plummeted 5.61% in pre-market trading on Monday, as analysts lowered their price targets on the company's stock, citing concerns about its future prospects.
In a research note released on Friday, J.P. Morgan cut its price target on ArcBest to $108 from $117, while Morgan Stanley slashed its target to $145 from $160. Wells Fargo also lowered its price target on the stock to $96 from $105.
The analysts' downgrades reflect concerns about the potential impact of macroeconomic factors on ArcBest's business performance. The transportation and logistics company has been grappling with rising costs and supply chain disruptions, which could weigh on its profitability in the coming quarters.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.